• Indian Indices
  • Global Indices
  • Commodities
  • Currency
Sensex
  • Sensex
  • Nifty
{{x.close_price| number:2}} {{x.netchg| number:2}} ({{x.perchg | number:2}}%)
Open - {{x.open | number:2}}
Prev Close - {{x.prevclose|number:2}}
Today's High - {{x.high|number:2}}
Today's Low - {{x.low|number:2}}
Advances/Declines (30 Companies)
  • 1D
  • 1W
  • 1M
  • 1Yr
  • 5Yr
{{x.upd_time}}
FTSE 100
  • FTSE 100
  • DJIA
  • NIKKEI 225
  • HANG SENG
{{x.Date}}
{{x.close| number:2}} {{x.Chg | number:2}} ({{x.PChg | number:2}}%)
Open - {{x.close | number:2}}
Prev Close - {{x.PrevClose|number:2}}
Gold
  • Gold
  • Silver
  • Crude Oil
  • Copper
{{x.Trd_Date}} ( {{x.Time}} )
{{x.ClosePrice| number:2}} {{x.change| number:2}} ({{x.perchange | number:2}}%)
Exchange - MCX
Open - {{x.Open|number:2}}
Exp Date - {{x.Exp_Date}}
Today's High - {{x.High|number:2}}
Prev. Close - {{x.PrevClose|number:2}}
Today's Low - {{x.Low|number:2}}
USDINR
  • USDINR
  • GBPINR
  • EURINR
  • JPYINR
{{x.Lasttrdtime}} ( {{x.Time}} )
{{x.ltp| number:2}} {{x.PriceDiff| number:2}} ({{x.PerChange | number:2}}%)
Exchange - NSE
Open - {{x.Open|number:2}}
Exp Date - {{x.Expirydate}}
Today's High - {{x.High|number:2}}
Prev. Close - {{x.PrevPrice|number:2}}
Today's Low - {{x.Low|number:2}}
As On 09-Dec-2022 13:52 PM
SENSEX
62,116.38
-454.30 (-0.73%)
NIFTY
18,488.95
-120.40 (-0.65%)
    No Companies Visited

Back to news list
  • Aarti Inds Q4 PAT up 39% YoY to Rs 194 crore

    Aarti Industries reported 39% rise in consolidated net profit to Rs 194 crore on a 49.8% increase in gross income from operations to Rs 2,018 crore in Q4 FY22 over Q4 FY21.

    Consolidated EBITDA jumped 30% YoY to Rs 339 crore during the period under review. EBITDA margin in Q4 FY22 was 16.8% as against 19.3% in Q4 FY21. Profit before tax in the fourth quarter stood at Rs 231 crore, up 34% from Rs 173 crore reported in the same period last year. Revenue from the speciality chemicals division increased 49% YoY to Rs 1,629 crore while the revenue from pharma division jumped 52% YoY to Rs 388 crore in Q4 FY22. The company's consolidated net profit surged to Rs 1,307 crore in FY22 from Rs 535 crore in FY21. Gross incomes from operations rose by 57.7% to Rs 7,919 crore in FY22 over FY21.

    Rajendra Gogri, chairman & MD, Aarti Industries, said: “We scaled new peaks during FY22 inspite of unprecedented pressures linked to inflation in input prices, in addition to elevated utility costs, disruptions in global supply chains and other challenges arising especially due to resurgent 2nd COVID wave. Moreover, it tested our ability to pass on these cost pressures. Given our long-standing relationship with our customers and time-tested business model, we have pass-through mechanisms in place which protected our margins.

    We have made healthy progress on some of our growth initiatives and have aggressive CAPEX plans lined up to realise our ambitions. Our investment across diversifying the product-mix, capacity enhancements in both speciality chemicals and pharmaceuticals, adding newer chemistries and range of products as well as strengthening our EHS standards will start contributing from the current fiscal year. This is based on healthy demand scenario prevalent in the domestic and export markets where India is seen as a reliable supplier.”

    The counter witnessed steep selling today. The scrip tumbled 6.16% to Rs 761.90 on the BSE. Till now, over 1.09 lakh shares of the company changed hands in the counter as against an average trading volume of 0.49 lakh shares in the past two weeks.

    A domestic brokerage reportedly noted that sequentially, the company's consolidated operating profit has fallen by 4% likely because the company ceased to account for compensatory receipts from Bayer AG since December.

    The media reported that the investors were disappointed by the management's guidance that consolidated operating profit will grow at high single digit in 2022-23, suggesting a year of consolidation ahead for the company.

    The slowdown in operating profit growth would be because of lack of receipts from Bayer and new projects at lower margins. Given the growth guidance, heavy capital expenditure and risk of global economic slowdown, the company's valuations are "still rich", the brokerage reportedly said.

    Aarti Industries is a manufacturer of specialty chemicals and pharmaceuticals.



    Back to news list
Previous Stories :
More






Hot Pursuit News

Quick Links

Market Statistics

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

The power of the database is harnessed by our fired-up reporters to generate interesting ideas. The reader-friendly presentation of the idea, supplemented by relevant data and information, can be accessed online through Capita Telefolio and Telefolio Gold. These ideas are used by individual investors as well as institutional investors to do further research and stay ahead.

Capital Market Publishers India Pvt. Ltd.

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071.
91-22-25229720
9769005430
Kindly note www.capitalmarket.com does not send any mobile SMS, whatsapp or twitter messages
giving any kind of stock recommendations.
For Capital Market Magazine queries mail to : subscription@capitalmarket.com
For Capital Market Online Products related queries mail to : financeshop@capitalmarket.com
For any other Capital Market Website related Queries mail to : info@capitalmarket.com
To advertise on Capital Market Websites & Capital Market Fortnightly magazine mail to : advt@capitalmarket.com
Flash News 09-Dec-2022
  •  ( 13:35) Sensex slides 441 pts, Nifty tad below 18,500 level, breadth negative  
  •  ( 13:30) Lupin launches Diclofenac Sodium Topical solution in US  
  •  ( 13:08) Vedanta board approves raising upto Rs 800 cr via NCD issue  
  •  ( 12:52) Bajaj Consumer board OKs Rs 81 crore share buyback  
  •  ( 12:35) Pharma shares advance  
  •  ( 12:35) Indices turn range bound; Nifty hovers near 18,550; Pharma shares advance  
  •  ( 12:25) L&T arm inks pact to acquire US-based OPRO.AI  
  •  ( 12:02) Ethos inks exclusive retail partnership deal with German brand Tutima  
  •  ( 11:53) KPI Green commissions 38.76 MWp solar power projects  
  •  ( 11:28) IT stocks decline  
  •  ( 11:27) Sensex, Nifty at the low point of the day  
  •  ( 11:02) Alembic Pharma gets USFDA nod for Desonide Cream  
  •  ( 10:57) Spandana Sphoorty board allots NCDs worth Rs 100 cr  
  •  ( 10:32) PSU banks in demand  
  •  ( 10:32) Indices turn red  
  •  ( 10:20) National Peroxide plant resumes operations  
  •  ( 09:48) RateGain Travel incorporates step down subsidiary in UAE  
  •  ( 09:28) Lupin appoints Spiro Gavaris as President of U.S. generics business  
  •  ( 08:49) Paytm board to mull share buyback on 13 Dec  
  •  ( 08:44) Asian stocks trading higher  
Show News
09 December 2022 13:49
3231.25
(0.33 %)
934.85
(-0.49 %)
6515.50
(-1.00 %)
1590.00
(-1.74 %)
825.00
(-0.97 %)
4381.00
(0.59 %)
2661.85
(-0.12 %)
1024.95
(-6.93 %)
1623.05
(0.22 %)
2729.65
(1.05 %)
926.60
(-0.53 %)
1196.40
(0.40 %)
1568.90
(-3.15 %)
339.50
(0.35 %)
1891.95
(-0.28 %)
2157.85
(-0.44 %)
1263.15
(-0.86 %)
8604.00
(-0.90 %)
20115.10
(1.57 %)
169.65
(-0.41 %)
217.15
(-0.28 %)
2614.95
(-1.30 %)
612.25
(0.09 %)
988.05
(0.72 %)
110.90
(-0.85 %)
3283.90
(-1.98 %)
1037.95
(-3.35 %)
2605.55
(0.86 %)
7094.90
(-1.11 %)
394.25
(-2.34 %)
Sensex 5min and Nifty 15min delayed as on .
Show Ticker
Rotate your device

Rotate your device

For the best experience please go back to portrait mode.